Skip to main content
. 2018 Apr 16;131(24):2720–2729. doi: 10.1182/blood-2018-02-831156

Figure 1.

Figure 1.

Treatment characteristics and cumulative mortality in 345 2-year survivors of autologous BMT in childhood, by treatment period. (A) Demographic and treatment characteristics of 2-year survivors of autologous BMT in childhood, by treatment era. CTX, cyclophosphamide; NB, neuroblastoma; NHB, non-Hispanic black; NHW, non-Hispanic whites. (B) Cumulative mortality in 2-year survivors of autologous BMT in childhood, by treatment era.